America December 18, 2020
Biogen to pay $22M to settle lawsuit over kickback scheme involving its multiple sclerosis drugs
Biogen Inc (NASDAQ: BIIB) agreed to pay $22 million to settle a lawsuit alleging it committed unlawful conduct involving its…
America December 18, 2020
Biogen Inc (NASDAQ: BIIB) agreed to pay $22 million to settle a lawsuit alleging it committed unlawful conduct involving its…
By Marivic Cabural Summers
Business March 21, 2019
The stock price of Biogen (NASDAQ: BIIB) suffered a steep decline after the biotechnology company announced its decision to stop…
By Cedric Dent